Filing Details

Accession Number:
0001209191-17-065918
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-15 16:21:16
Reporting Period:
2017-12-14
Accepted Time:
2017-12-15 16:21:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
786947 Acura Pharmaceuticals Inc ACUR Pharmaceutical Preparations (2834) 110853640
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1431759 B Robert Jones C/O Acura Pharmaceuticals, Inc.
616 N North Court
Palatine IL 60067
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-12-14 400,000 $0.10 412,555 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Reporting Person is among buyers of shares in a private transaction pursuant to a stock purchase agreement entered into with Galen Partners III, LP, Galen Employee Fund III, LP and Galen Partners International III, LP in connection with their disposition of substantially all of their shares of Issuer.